← All organizations
Highest phase reached
Phase 2
First clinical trial
Nov 30, 2019Last known activity
Oct 10, 2025
Timeline
2010s
- Jan 1, 2015
Guangzhou Bio-gene Technology Co., Ltd.— Founded
Drugs by trial phase (15 distinct, 20 trials)
Phase 2 (7 own, 0 via acquisition)
Phase 1 (7 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (20)
- NCT07196124Lead sponsorEarly Phase 1Oct 10, 2025
- NCT07196111Lead sponsorEarly Phase 1Oct 10, 2025
- NCT07195617Lead sponsorN/AOct 10, 2025
- NCT07123662Lead sponsorEarly Phase 1Sep 1, 2025
- NCT07152210Lead sponsorN/ASep 1, 2025
- NCT07152236Lead sponsorN/AAug 31, 2025
- NCT07152223Lead sponsorN/AAug 30, 2025
- NCT06932393Lead sponsorEarly Phase 1Apr 30, 2025
- NCT06820424CollaboratorEarly Phase 1Mar 31, 2025
- NCT06515262CollaboratorN/AJul 1, 2024
- NCT06347458Lead sponsorPhase 1Apr 30, 2024
- NCT06106906CollaboratorPhase 1/Phase 2Dec 31, 2023
- NCT06106893CollaboratorPhase 1/Phase 2Dec 31, 2023
- NCT06118788Lead sponsorPhase 1/Phase 2Nov 30, 2023
- NCT06068400Lead sponsorN/ASep 13, 2023
Details
- Founded
- Guangzhou, CN Jan 1, 2015
- Last known activity
- Oct 10, 2025